Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on which to base the diagnosis of PCOS.
Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause / Genazzani, A.D., Fedora, A., Giulia, D., Alba, M., Martina, C., Melania, A., Tabatha, P., Veronica, T., Genazzani, A.R. (ISGE SERIES). - In: Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health[s.l] : Springer Nature, 2021. - pp. 67-74 [10.1007/978-3-030-63650-0_6]
Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause
Genazzani A. D.;Martina C.;
2021
Abstract
Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on which to base the diagnosis of PCOS.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
